Acute Hemorrhagic Edema of Infancy by Hayrullah Alp
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Acute Hemorrhagic Edema of Infancy 
Hayrullah Alp 
Selcuk University Meram Medical Faculty,  
Department of Pediatrics 
Turkey 
1. Introduction  
Acute hemorrhagic edema of infancy (AHEI) is a benign cutaneous small vessel 
leucocytoclastic vasculitis. The disease characterized by low-grade fever, acral inflammatory 
edema and large rosetta-, annular-, or targetoid-shaped ecchymotic purpura primarily over 
the face and extremities. The outbreak is frequently preceded by an immunization, drug 
intake or various infections. In spite of violent and alarming clinical presentation in a non-
toxic infant, spontaneous recovery without any sequelaes occurs within a few weeks. 
Although some have suggested that AHEI is a purely cutaneous variant of Henoch-
Schönlein purpura, most authors prefer to regard it as a separate clinical entity among the 
cutaneous small vessel vasculitic diseases of infancy.  
2. Background 
Although, AHEI was first described by Snow as a purely cutaneous variant of Henoch-
Schönlein purpura in American literature in 1913 (Snow, 1913), it was well-recognised by 
Seidlmayer (Seidlmayer, 1936) and Finkelstein (Finkelstein, 1938) in European literature in 
1930ies. Since then in Europe, many cases have been reported under different clinical terms, 
including Finkelstein disease and Seidmayer’s ‘cockade’ purpura or syndrome. The name 
AHEI first appeared in Spanish written and used by Del Carril (Del Carril et al., 1936). Other 
names used for the disease include purpura en cocarde avec oedema, urticarial vasculitis of 
infancy, acute benign cutaneous leukocytoclastic vasculitis (Saraclar et al., 1990) of infancy 
and infantile post-infectious iris-like purpura and oedema. Already, more than 100 cases of 
AHEI have been published in medical literature worldwide. However, the current number 
of reported cases are being still unknown. This is probably because, the most papers on the 
subject being written different languages in the world and AHEI is called Henoch-Schönlein 
purpura in the United States. Although most of the prints were in case reports (Babic et al., 
2008; Can et al., 2006; Di Lernia et al., 2004; Garty et al., 2002; Michael, 2006; Millard et al., 
1999; Macea et al., 2003; Obeid et al., 2008; Serna et al., 1994, Silveira & Braganca, 2006), case 
series were also published (Alp et al., 2009; Caksen et al., 2002; Fiore et al., 2008; Gelmetti et 
al., 1985; Gonggryp & Todd, 1998; Ince et al., 1995; Karremann et al., 2009; Krause et al., 
1996; Legrain et al., 1991; Poyrazoglu et al., 2003; Saraclar et al., 1990; Sites et al., 2008). 
Today, AHEI is considered as a separate entity, but not a variant of Henoch-Schönlein 
purpura, with clinical findings and prognosis.  
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The exact incidence of AHEI is not well known because of rarity of the disease. So, 
multicenter epidemiologic studies are needed.  Some authors believe that AHEI is often 
mistaken for other diseases and, therefore, its incidence may be more frequent. It is also 
probable that, using the synonyms for AHEI in the same population for different cases and 
to consider the disease as Henoch-Schönlein purpura may change the incidence.  
3.1 Age 
Usually, AHEI affects infants between 4 months and 2 years of age. However, cases at birth 
(Cunningham et al., 1996, 1999) and over 2 years of age (Alp et al., 2009; Dubin et al., 1990; 
Poyrazoglu et al., 2003; Slutsky et al., 2010), with classical features of AHEI, have been 
reported. Also, rare cases have been reported in older children up to 60 months of age (Alp 
et al., 2009; Fiore et al., 2008; Legrain et al., 1991). So, it can be suggested that AHEI can be 
diagnosed from newborn to 60 months of age. Actually, newly added reports of AHEI in 
English literature between 2008 and 2010 (Alp et al., 2009; Babic et al., 2008; Cicero, 2008; 
Ferraira et al., 2010; Fiore et al., 2008; Halıcıoglu et al., 2010; Jain & Patel, 2008; Javidi et al., 
2008; Kumar et al., 2008; Karremann et al., 2009; Obeid et al., 2008; Slutsky et al., 2010; Sites 
et al., 2008) with the review by AlSufyani (AlSufyani, 2009) make the mean age 
approximately 16.56 months instead of 13.75 months reported by Alsufyani (Alsufyani, 
2009). Indeed, there have been some reports of cases occurring beyond the age of 3 years; 
however, these cases have the features that overlap with those of Henoch-Schönlein purpura 
(Legrain et al., 1991; Shah et al., 2002).  
3.2 Sex 
Male predominance is clear in the literature. Case series are also support this data (Alp et al., 
2009; Fiore et al., 2008; Ince et al., 1995; Legrain et al., 1991; Poyrazoglu et al., 2003; Saraclar 
et al., 1990). Also, AlSufyani suggests the male to female ratio approximately 4.64/1 
(AlSufyani, 2009). However, adding the reported cases between 2008 and 2010 (Alp et al., 
2009; Babic et al., 2008; Cicero, 2008; Ferraira et al., 2010; Fiore et al., 2008; Halıcıoglu et al., 
2010; Jain & Patel, 2008; Javidi et al., 2008; Kumar et al., 2008; Karremann et al., 2009; Obeid 
et al., 2008; Slutsky et al., 2010; Sites et al., 2008) makes the male to female ratio 
approximately 4.34/1. Also, Fiore and colleagues reported the ratios of boys as %67 and 
girls as %33 in their systematic review (Fiore et al., 2008). But, they have reviewed 155 
reports written in 6 languages, not only English literature. 
3.3 Effect of seasons 
AHEI, usually presents during the winter months. This may be associated with its potential 
etiology. However, some have presented in the spring, autumn (Fiore et al., 2008; Legrain et 
al., 1991; Poyrazoglu et al., 2003) and summer (Saraclar et al., 1990). 
4. Etiology and pathogenesis 
AHEI is probably an immune complex-mediated vasculitis and the pathophysiology is 
still not fully understood. The frequency of preceding infections and seasonal variation 
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indicate an infective cause, but drugs and/or immunizations are also suspected. Legrain 
(Legrain et al., 1991) and AlSufyani (Alsufyani, 2009) reported these related causes up to 
%75 and %84.6 respectively. Obviously, it is difficult to attribute AHEI to an infection, 
drug or immunization as these are often present together; however, a few case reports 
have shown clearance of the first attack, as well as relapses, of AHEI after appropriate 
treatment of the associated infections (Dubin et al., 1990; Gonggryp & Todd, 1998; Ince et 
al., 1995; Morrison et al., 1999; Tomac et al., 1996). In addition, Cunningham and 
colleagues (Cunningham et al., 1996, 1999) have reported a newborn with the clinical 
findings of AHEI. Her mother had severe gastroenteritis 6 weeks prior to delivery and 
many lesions on the baby were faded and faint, suggesting that the process had evolved 
in utero. In conclusion, the authors hypothesized that there was a maternal-fetal transfer 
of the infectious agent or the immune complex triggering the skin lesions. This probably 
supports the role of infections and immune complexes in the pathogenesis of AHEI. Other 
infections described as prodromes that have been accused in the pathogenesis are upper 
respiratory tract infections (Alp et al., 2009; Babic et al., 2008; Blasini et al., 2007; Caksen et 
al., 2002; Dubin et al., 1990; Fiore et al., 2008; Gelmetti et al., 1985; Halıcıoglu et al., 2010; 
Ince et al., 1995; Karremann et al., 2009; Kumar et al., 2008; Lai-Cheong JE et al., 2007; 
McDougall et al., 2004; Michael, 2006; Millard et al., 1999; Paradisi et al., 2001; Poyrazoglu 
et al., 2003; Saraclar et al., 1990), pharyngitis (Gattorno et al., 1997; Gonggryp & Todd, 
1998), tonsillitis (Legrain et al., 1991; Karremann et al., 2009), otitis (Caksen et al., 2002; 
Crowe et al., 1998; Karremann et al., 2009; Krause et al., 1996; Lantner et al., 1996; Macea 
et al., 2003), conjunctivitis (Legrain et al., 1991), neck abscess, bronchopneumonia (Alp et 
al., 2009; Saraclar et al., 1990), bronchitis (Karremann et al., 2009), pneumococcal 
bacteremia (Morrison et al., 1999), pulmoner tuberculosis (Gonggryp & Todd, 1998), 
cellulitis (Can et al., 2006), urinary tract infections (Saraclar et al., 1990) and gastroenteritis 
(Caksen et al., 2002; Chatproedprai & Wananukul, 2007; Fiore et al., 2008; Garty et al., 
2002; Poyrazoglu et al., 2003; Silveira & Braganca, 2006).  
Also, specific microorganisms have been isolated in the cases with AHEI, such as coxsackie 
B4 virus (Krause et al., 1996), cytomegalovirus (Kuroda et al., 2002; Saraclar et al., 1990), 
rotavirus (Di Lernia et al., 2004), herpes simplex virus-1 (Garty et al., 2006), hepatitis A virus 
(Bozaykut et al., 2002) and parvovirus B19 (Erguven & Karaca Atakan, 2009). Escherichia 
coli grew in some of the children with urinary tract infections (Fiore et al., 2008) and 
campylobacter (Gonggryp & Todd, 1998) were isolated in some of the patients with 
diarrhea. Additionally, failure to convincingly relate AHEI to prodromal infectious caused 
by group A streptococcus or Mycoplasma pneumoniae is not surprising, considering that 
these agents mostly cause infections in children 5 years of age or older (Jaggi & Shulman, 
2006; Principi & Esposito, 2002). 
A wide range of medications have been reported such as anti-inflammatory and/or 
antipyretics including ibuprofen (Blasini et al., 2007), aspirin and paracetamol (da Silva 
Manzoni et al., 2004; Fiore et al., 2008; Karremann et al., 2009; Legrain et al., 1991; 
Poyrazoglu et al., 2003; Saraclar et al., 1990), antimicrobials including penicillins (Legrain et 
al., 1991; Saraclar et al., 1990), amoxicillin (Blasini et al., 2007; Gattorno et al., 1997), 
sultamisilin (Halıcıoglu et al., 2010), erythromycin (Krause et al., 1996), tobramycin (Blasini 
et al., 2007), trimethoprim-sulfomethoxazol (Poyrazoglu et al., 2003), cefaleksin (Crowe et 
al., 1998; da Silva Manzoni et al., 2004;), ceftriaxone (Can et al., 2006), ceftibuten (Fiore et al., 
www.intechopen.com
 Advances in the Etiology, Pathogenesis and Pathology of Vasculitis 
 
378 
2008) and other medications such as cough syrup (Dubin et al., 1990; Gonggryp & Todd, 
1998) and probiotics (Fiore et al., 2008).  
Vaccines have also been implicated in the pathogenesis of AHEI, including diphtheria-
pertussis-tetanus (Krause et al., 1996; Saraclar et al., 1990), poliomavirus vaccine (Saraclar et 
al., 1990), hemophilus influenza conjugated (Krause et al., 1996), measles (Gonggryp & 
Todd, 1998; Saray et al., 2002), rubeola (Poyrazoglu et al., 2003), BCG (Lai-Cheong JE et al., 
2007) and influenza A/H1N1 vaccine (Ferraira et al., 2010).  
In the skin, postcapillary venules are the most commonly involved vessels. Leucocytoclastic 
vasculitis is the histological feature of AHEI that has been linked pathogenetically to 
immune complex deposition, complement activation and chemotaxis of neutrophils, with 
secondary damage to vessel walls due to the release of enzymes by activated neutrophils 
(Legrain et al., 1991, Saraclar et al., 1990). However, complement deficiency (Yavuz, 2000) or 
hypocomplementemia due to activation of the classical pathway of complement system 
(Watanabe & Sato, 2007) have not been showed in AHEI as they have been suggested. The 
location of vasculitic lesions to the extremities and especially the legs in children is thought 
to be related to increased hydrostatic pressure leading to immune complexes and fibrin 
deposition (Legrain & Taieb, 2000). Also, it has been suggested that proportionally larger 
had and face in infants corresponds to increased blood supply and susceptibility to facial 
purpura (Amitai et al, 1993).  
5. Histopathology 
Classically histological examination shows features of an intense dermal leucocytoclastic 
vasculitis involving small blood vessels in the dermis with (Acun et al., 2006; AlSufyani, 
2009; Blasini et al., 2007; Braun-Falco & Dietrich Abeck, 2002; Caksen et al., 2002; Calıskan et 
al., 1995; Can et al., 2006; Chatproedprai & Wananukul, 2007; Colantonio et al., 1997; Crowe 
& Jonas, 1998; Cunningham et al., 1996, 1999; Bozaykut et al., 2002; da Silva Manzoni et al., 
2004; Di Lernia et al., 2004; Dubin et al., 1990; Fiore et al., 2008; Fujimura et al., 2001; Garty et 
al., 2006; Gelmetti et al., 1985; Goraya & Kaur, 2002; Gonggryp & Todd, 1998; Gattorno et al., 
1997; Javidi et al., 2008; Krause et al., 1996; Kuroda et al., 2002; Lakshmi & Srinivas, 2003; 
Lantner et al., 1996; Lee et al., 2006; Long & Helm, 1998; Macea et al., 2003; Michael, 2006; 
Millard et al., 1999; Morrison & Saulsbury, 1999; Paradisi et al., 2001; Poyrazoglu et al., 2003; 
Pride et al., 1995; Roh et al., 2004; Tomac et al., 1996; Saray et al., 2002; Scaramuzza et al., 
1997; Serna et al., 1994; Shah et al., 2002; Silveira et al., 2006; Sites et al., 2008; Smitt et al., 
2002, Watanabe & Sato, 2007; Wong & Harrington, 2004) (Fig. 1a, b) or without (Ince et al.,  
1995; Legrain et al., 1991; Saraclar et al., 1990) fibrinoid necrosis and erythrocyte 
extravasation. However, lymphohistiocytic perivascular infiltration with extravasation of 
erythrocytes and without fibrinoid necrosis was also reported by Legrain and colleagues 
(Legrain et al., 1991). The infiltrating inflammatory cells are predominantly neutrophils with 
less number of eosinophils (Krause et al., 1996; Macea et al., 2003; Millard et al., 1999; 
Saraclar et al., 1990). 
6. Immunofluorescence study and immunologic characteristics 
Immunofluorescence studies are usually negative (AlSufyani, 2009; Can et al., 2006; 
Cunningham et al., 1996; da Silva Manzoni et al., 2004; Gonggryp & Todd, 1998; Javidi et al.,  
www.intechopen.com




Fig. 1a. Hematoxylin and eosin-stained pathologic specimen from a purpuric skin lesion, 
showing perivascular leucocyte infiltration (x10). 
 
 
Fig. 1b. Extravasation of red blood cells, neutrophilic perivascular infiltration with 
leukocytoclasia, and fibrinoid necrosis (x40). 
2008; Krause et al., 1996; Legrain et al., 1991; Paradisi et al., 2001; Serna et al., 1994). 
However; C3, C1q, fibrinogen, IgM, IgG, IgE and IgA were detected in the specimens with 
varying degrees of positivity (Amitai et al., 1993; Blasini et al., 2007; Caksen et al., 2002; 
Chatproedprai & Wananukul, 2007; Garty et al., 2006; Gattorno et al., 1997; Kuroda et al., 
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2002; Legrain et al., 1991; Long & Helm, 1998; Michael, 2006; Paradisi et al., 2001; Roh et al., 
2004; Tomac et al., 1996; Saraclar et al., 1990). In the study of Saraclar and colleagues, in the 
skin biopsy of 9 cases perivascular C3, fibrinogen, IgM, IgG, IgE and IgA were detected 
100%, 100%, 78%, 22%, 33% and 33% respectively (Saraclar et al., 1990). After the publication 
of their article they also examined an infant and in the lesional skin biopsy specimens of 
these 10 cases IgA, IgG, IgM, IgE and C1q depositions were found in 30%, 20%, 80%, 30% 
and 100% respectively (Saraclar et al., 1992). So, based on these findings they suggested that 
the presence of C1q and absence or infrequency of IgA deposition may help physicians to 
confirm AHEI rather than Henoch-Schönlein purpura. Additionally, Fiore et al. reported the 
deposition of IgA as 24% in their review (Fiore et al., 2008). Watanabe & Sato reported 
decreased levels of C4, C1q and CH50 in the serum of a 19-month-old boy with AHEI 
(Watanabe & Sato, 2007). So, they suggested that activation of the classical pathway of the 
complement might represent one of the pathogenic mechanisms underlying the 
development of AHEI. In summary, all of these immunohistologic and immunoserologic 
findings indicate that AHEI is an immunorelated disease.  
 
 
Fig. 2. Immunofluorescence study of epidermis with deposition of perivascular IgA.  
7. Clinical features 
The characteristic clinical features of AHEI are fever, purpura and edema. Additionally, the 
most striking feature is the contrast between the acuteness of the cutaneous signs and the 
good general condition of the child (Alp et al., 2009; Amitai et al., 1993; Dubin et al., 1990; 
Fiore et al., 2008; Ince et al., 1995; Lantner & Simon, 1996; Tomac et al., 1996; Saraclar et al., 
1990). In the review of Fiore and colleagues, general appearance was reported as severely 
reduced in 1.0%, mildly reduced in 7.0% and very satisfactory in remaining 92% (Fiore et al., 
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2008). Additionally, atypical presentations such as painful edema (Dubin et al., 1990; 
Gonggryp & Todd, 1998; Krause et al., 1996; Lantner & Simon, 1996; Millard et al., 1999; 
Morrison & Saulsbury, 1999; Shah et al., 2002), itching (AlSufyani, 2009; Caksen et al., 2002), 
irritability (Crowe & Jonas, 1998; Kuroda et al., 2002; Lantner & Simon, 1996) and decreased 
appetite (Lantner & Simon, 1996) may occur. Fever is typically low grade, but may range 
from mild to severe and also afebrile cases have been published in the literature (AlSufyani, 
2009; Amitai et al., 1993; Dubin et al., 1990; Fiore et al., 2008; Gonggryp & Todd, 1998; 
Karreman et al., 2009; Krause et al., 1996; Saraclar et al., 1990; Scaramuzza et al., 1997; Serna 
et al., 1994). In the review of Fiore and colleagues fever of low grade was reported in 45% of 
the children (Fiore et al., 2008).  
Purpura is the most dramatically presenting exanthema of AHEI and often appears in a 
cockade pattern in combined lesions (Legrain et al., 1991; Saraclar et al., 1990; Seildmayer, 
1936). The erupsion usually starts with erythematous macules (Krause et al., 1996; 
Scaramuzza et al., 1997), papules (Lantner & Simon, 1996; McDougall et al., 2004; Tomac et 
al., 1996), or urticarial plaques (da Silva Manzoni et al., 2004; Legrain et al., 1991; Saraclar et 
al., 1990) that rapidly progress into annular (Lee et al., 2006; McDougall et al., 2004), 
rounded or oval (Alp et al., 2009), medallion-like (Karreman et al., 2009), cockade (Caksen et 
al., 2002), or targetoid-shaped purpuric lesions (Alp et al., 2009; Amitai et al., 1993; Caksen et 
al., 2002, Calıskan et al., 1995; Can et al., 2006; Crowe & Jonas, 1998; Cunningham et al., 1996; 
da Silva Manzoni et al., 2004; Di Lernia et al., 2004; Dubin et al., 1990; Fiore et al., 2008; 
Gelmetti et al., 1985; Gonggryp & Todd, 1998; Ince et al., 1995; Krause et al., 1996; Lantner & 
Simon, 1996; Lee et al., 2006; Legrain et al., 1991; Long & Helm, 1998; McDougall et al., 2004; 
Poyrazoglu et al., 2003; Saraclar et al., 1990; Scaramuzza et al., 1997; Serna et al., 1994; 
Silveira et al., 2006; Tomac et al., 1996; Watanabe & Sato, 2007) (Fig. 1a, b). However, other 
morphologies have been described, such as reticulated (Legrain et al., 1991), petechiael 
(Karreman et al., 2009), rosette-like (Paradisi et al., 2001), scalloped-border (Millard et al., 
1999; Yu et al., 2007), tense hemorrhagic blistered or fluid containing lesions (either vesicles 
or bullae) (Al-Sheyyab et al., 1995; da Silva Manzoni et al., 2004; Gonggryp & Todd, 1998; 
Gattorno et al., 1997; Gattorno et al., 1999; Lai-Cheong et al., 2007; Lee et al., 2006; Legrain et 
al., 1991; Millard et al., 1999; Suehiro et al., 2007; Watanabe & Sato, 2007), arcuate and 
polycyclic (Di Lernia et al., 2004; Macea et al., 2003). Skin lesions may progress to 1 to 6 cm 
in diameter (Michael, 2006; Smitt et al., 2002). The rashes are usually sharped edged and the 
centre of the lesions may rarely have the colour of the normal skin (Legrain et al., 1991; 
Saraclar et al., 1990). Lesions usually occur in the face (mainly cheeks) (Alp et al., 2009; 
AlSufyani, 2009; Caksen et al., 2002; Fiore et al., 2008; Karreman et al., 2009; Krause et al., 
1996; Legrain et al., 1991; Poyrazoglu et al., 2003; Saraclar et al., 1990), auricles (Fig. 2) and 
upper (Millard et al., 1999) (Fig. 3) or lower extremities (Alp et al., 2009; AlSufyani, 2009; 
Caksen et al., 2002; Fiore et al., 2008; Karreman et al., 2009; Krause et al., 1996; Legrain et al., 
1991; Michael, 2006; Poyrazoglu et al., 2003; Saraclar et al., 1990) (Fig. 4) with relative 
sparing of the trunk (Fiore et al., 2008). Additionally, Fiore and colleagues reviewed that 
purpura had a relative frequency on the left side of the body (Fiore et al., 2008). Skin or 
mucous membranes are uncommonly involved in AHEI such as conjunctiva (McDougall et 
al., 2004; Poyrazoglu et al., 2003), buccal mucosa (Halıcıoglu et al., 2010; Roh et al., 2004), 
palate (Blasini et al., 2007; Chatproedprai & Wananukul, 2007; Gelmetti et al., 1985; 
Poyrazoglu et al., 2003), gums (Di Lernia et al., 2004), uvula, tongue, pharynx (Amitai et al., 
1993; Di Lernia et al., 2004; Dubin et al., 1990; Krause et al., 1996; McDougall et al., 2005), calf 
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Fig. 3a. Purpuric involvement of the feet in a 30-month-old male patient with AHEI. 
 
 
Fig. 3b. Ecchymotic and purpuric lesions with edema of the lower extremities in a 7-month-
old girl.  
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(as hematoma) (Karreman et al., 2009), penis (Fiore et al., 2008; Poyrazoglu et al., 2003), 
scrotum (Dubin et al., 1990; Karreman et al., 2009; Poyrazoglu et al., 2003), buttocks (Amitai 
et al., 1993; da Silva Monzani et al., 2004; Legrain et al., 1991; Michael, 2006; Paradisi et al., 
2001; Roh et al., 2004; Saraclar et al., 1990; Serna et al., 1994; Shah et al., 2002), joints (Al-
Sheyyab et al., 1995; Gattorno et al., 1997) and perineum (Lantner & Simon, 1996). 
Extracutaneous manifestations rarely occur; however, renal involvement with microscopic 
hematuria, proteinuria and hypocomplementemia (Watanabe & Sato, 2007); transient and 
microscopic hematuria (Al-Sheyyab et al., 1995; Amitai et al., 1993; Gonggryp & Todd, 1998; 
Legrain et al., 1991; Millard et al., 1999); intusseption (Yu et al., 2007); bowel involvement as 
positive stool for occult blood (Al-Sheyyab et al., 1995; Di Lernia et al., 2004; Garty et al., 
2002; Gonggryp & Todd, 1998; Yu et al., 2007) and abdominal pain with elevated 
transaminases (Obeid et al., 2008) associated with AHEI were reported. Proteinuria is 
usually transient (Legrain et al., 1991; Saraclar et al., 1990), but can be persistent (Millard et 
al., 1999). Hypertension is also rare and transient (Caksen et al., 2002) with no renal 
involvement. Cases of diarrhea, abdominal pain and vomiting have been reported (Di 
Lernia et al., 2004; Legrain et al., 1991), however these cases have shown an underlying 
cause, such as coxsackie virus (Legrain et al., 1991) and rotavirus (Di Lernia et al., 2004) 
growth in the stool. 
 
 
Fig. 4. Purpuric skin lesion on ear in a 11-month-old boy with AHEI. 
Edema is classically asymmetrical nonpitting (mainly tender), usually affects the auricles, 
face and limbs (frequently dorsum of the hands and feet) (Alp et al., 2009; AlSufyani, 2009; 
Amitai et al., 1993; Caksen et al., 2002, Calıskan et al., 1995; Can et al., 2006; Crowe & Jonas, 
1998; Cunningham et al., 1996; da Silva Manzoni et al., 2004; Di Lernia et al., 2004; Dubin et 
al., 1990; Fiore et al., 2008; Garty et al., 2006; Gonggryp & Todd, 1998; Ince et al., 1995; 
Krause et al., 1996; Lantner & Simon, 1996; Lee et al., 2006; Legrain et al., 1991; Long & Helm, 
1998; McDougall et al., 2004; Michael, 2006; Millard et al., 1999; Paradisi et al., 2001; 
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Fig. 5. Ecchymotic and purpuric lesions of upper extremities in a 10-month-old girl. 
 
 
Fig. 6. Ecchymotic and purpuric lesions of the lower extremities in a 7-month-old girl.  
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Poyrazoglu et al., 2003; Saraclar et al., 1990; Scaramuzza et al., 1997; Serna et al., 1994; 
Silveira et al., 2006; Tomac et al., 1996; Watanabe & Sato, 2007). However, other parts of the 
body may be involved resembling nephrotic syndrome such as the eyelids (Caksen et al., 
2002; Gonggryp & Todd, 1998; Karreman et al., 2009; Legrain et al., 1991; Paradisi et al., 
2001; Saraclar et al., 1990), lips (McDougall et al., 2004), penis (Fiore et al., 2008; Poyrazoglu 
et al., 2003) and scrotum (Millard et al, 1999; Saraclar et al., 1990; Yu et al., 2007). Also, the 
edema can cause weight gain (Saraclar et al., 1990).  
8. Laboratory findings 
The laboratory investigations are nonspecific. Leukocytosis with lymphocytosis or 
eosinophilia (Alp et al., 2009; Amitai et al., 1993; Colantonio et al ., 1997; Cunningham et al., 
1996; Fiore et al., 2008; Lantner & Simon, 1996; Legrain et al., 1991; Roh et al., 2004; Tomac et 
al., 1996; Saraclar et al., 1990; Scaramuzza et al., 1997; Watanabe & Sato, 2007), 
thrombocytosis (Di Lernia et al., 2004; Fiore et al., 2008; Garty et al., 2006; Halıcıoglu et al., 
2010; Ince et al., 1995; Lantner & Simon, 1996; Legrain et al., 1991; Tomac et al., 1996) and 
increased erythrocytes sedimentation rate or C-reactive protein (Alp et al., 2009; AlSufyani, 
2009; Blasini et al., 2007; Caksen et al., 2002; Can et al., 2006; Colantonio et al ., 1997; Di 
Lernia et al., 2004; Fiore et al., 2008; Garty et al., 2002; Halıcıoglu et al., 2010; Javidi et al., 
2008; Kuroda et al., 2002; Lee et al., 2006; Macea et al., 2003; Millard et al., 1999; Paradisi et 
al., 2001; Poyrazoglu et al., 2003; Watanabe & Sato, 2007) are common findings.The 
coagulation tests are usually normal, but elevated fibrinogen (Di Lernia et al., 2004) was 
noted. Additionally, hypoalbunemia has been reported associated with intusseption (Yu et 
al., 2007). Urinalysis is frequently normal, however cases of proteinuria (Legrain et al., 1991; 
Saraclar et al., 1990; Watanabe & Sato, 2007) and microscopic hematuria (Al-Sheyyab et al., 
1995; Amitai et al., 1993; Gonggryp & Todd, 1998; Legrain et al., 1991; Millard et al., 1999; 
Watanabe & Sato, 2007) have been reported. The stool is typically negative for blood, but 
positive stool for occult blood (Al-Sheyyab et al., 1995; Di Lernia et al., 2004; Garty et al., 
2002; Gonggryp & Todd, 1998; Yu et al., 2007) have been documented. Antinuclear 
antibodies (ANAs), ASO titre, antideoxyribonucleic acid (anti DNA) antibodies and 
rheumatoid factor are always negative. However, elevated anti-DNAse B titer (Gonggryp & 
Todd, 1998) and IgG antineutrophil cytoplasmic antibody (Ozaltın et al., 2004) have been 
reported in two patients. Complement levels are normal in the patients, although cases with 
increased serum C3 (Saraclar et al., 1990), decreased serum C4 (Cunningham et al., 1996; 
Watanabe & Sato, 2007) and CH50 (Watanabe & Sato, 2007) levels have been mentioned. 
Classically, serum immunoglobulin levels are normal, however patients with increased 
levels of IgG (Legrain et al., 1991), IgM (Caksen et al., 2002; Di Lernia et al., 2004), IgE 
(Saraclar et al., 1990) and IgA (Di Lernia et al., 2004; Legrain et al., 1991) have been reported. 
Circulating immune complexes are normal, although some have reported positive findings 
(Saraclar et al., 1990; Scaramuzza et al., 1997). Additionally, Ozaltın and colleagues reported 
positivity of IgG ANCA in a patient with AHEI (Ozaltın et al., 2004). However, the 
importance of this finding has not been known. Generally, most of these uncommon 
laboratory findings are case reports and need future evaluations.   
9. Diagnostic criteria and differential diagnosis 
The diagnostic criteria can be proposed as follows (AlSufyani, 2009; Krause et al., 1996). 
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a. Between 4 months and 2 years of age. 
b. Purpuric or ecchymotic target-like skin lesions with edema especially on the face, 
auricles and extremities with or without mucosal involvement.  
c. Lack of systemic disease or visceral involvement. 
d. Spontaneous recovery within 4-24 days. 
Common laboratory investigations are follows. 
a. Leukocytosis with lymphocytosis or eosinophilia. 
b. Elevated erythrocytes sedimentation rate or C-reactive protein. 
c. Leucocytoclastic vasculitis with or without fibrinoid necrosis involving small blood 
vessels in the dermis on histological examination.  
d. Negative immunofluorescence studies are usual or rarely positivity of C3, C1q, 
fibrinogen, IgM, IgG, IgE and IgA in varying degrees can be detected. 
AHEI and Henoch-Schönlein purpura (HSP) both fall within the spectrum of the 
leucocytoclastic vasculitis. Some authors believe that these two conditions are different 
disease entities (Cunningham et al., 1999; da Silva Manzoni et al., 2004; Gonggryp & Todd, 
1998; Ince et al., 1995; Krause et al., 1996; Millard et al., 1999; Saraclar et al., 1990; Tomac et 
al., 1996) whereas others regard them as distinct but with some cases showing overlap 
(Legrain et al., 1991; Shah et al., 2002). Some of the points that differentiate these two entities 
are (Table 1); age of onset (3-7 years for HSP and 4 months-2 years for AHEI) (Legrain et al.,  
 
 AHEI HSP 
Age 4-24 months 3-7 years 
Sex Slight male predominance in both diseases 
Prodromes 
Respiratory infections, drug intake and immunization 
in both diseases 
Seasons Usually winter months in both diseases 
Morphology of skin lesions 
Purpuric, ecchymotic 
lesions 
Papular, petechial and 
urticarial lesions 
Location of skin lesions 
Face, auricles and 
extremities with relative 
frequency on the left side 
of the body 
Lower parth of the body 
Edema 
Constant and nonpitting, 
mainly tender 
Inconsistent 
Visseral involvement Uncommon Frequent 
Duration of disease 1-3 weeks One month or more 
Relapses Rare Frequent 
Histopathology 
Leucocytoclastic vasculitis 




Immunofluorescence study Perivascular C1q deposits 
Perivascular IgA 
deposits 
Table 1. Comparison of epidemiological, clinical and pathological findings of AHEI and 
HSP 
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1991; Saraclar et al., 1990; Tomac et al., 1996), morphology of skin lesions with location on 
the part of the body (papular, petechial, urticarial lesions located predominantly on the 
lower legs and gluteal regions in HSP and ecchymotic, cockade purpuric lesions mainly 
located on face and extremities in AHEI) (Legrain et al., 1991; Saraclar et al., 1990; Tomac et 
al., 1996), edema (not a clinical finding of HSP, but a classical finding of AHEI, commonly 
nonpitting with tender) (Legrain et al., 1991; Saraclar et al., 1990; Tomac et al., 1996), visceral 
involvement (frequently seen in HSP, but uncommon in AHEI) (Gelmetti et al., 1985;  
Legrain et al., 1991; Saraclar et al., 1990), duration of disease (one month or more in HSP, 
usually resolves between 1-3 weeks in AHEI) (Fiore et al., 2008; Legrain et al., 1991; Saraclar 
et al., 1990) and relapses (frequent in HSP, rare in AHEI, however there have been cases of 
AHEI showing multiple relapses) (Amitai et al., 1993; Dubin et al., 1990; Karreman et al., 
2009; Legrain et al., 1991; Saraclar et al., 1990). 
Also, duration of complete recovery in each attack is different between HSP (approximately 
4 weeks) and AHEI (approximately 12 days) (Karreman et al., 2009; Legrain et al., 1991; 
Tomac et al., 1996). However, there have been cases of AHEI with long duration of attacks 
up to 24 days (Legrain et al., 1991). On laboratory, some authors suggested that these two 
diseases should be separated on the basis of the negative immunofluorescence studies of 
skin biopsies in the cases with AHEI (Millard et al., 1999; Saraclar et al., 1990). Although, as 
it was discussed in ‘Immunofluorescence study and immunologic characteristics’ some 
reported cases had positive direct immunofluorescence with any of C3, C1q, fibrinogen, IgM, 
IgG, IgE and IgA (Amitai et al., 1993; Blasini et al., 2007; Caksen et al., 2002; Chatproedprai 
& Wananukul, 2007; Garty et al., 2006; Gattorno et al., 1997; Kuroda et al., 2002; Legrain et 
al., 1991; Long & Helm, 1998; Michael, 2006; Paradisi et al., 2001; Roh et al., 2004; Tomac et 
al., 1996; Saraclar et al., 1990). However, Saraclar and colleagues suggested that presence of 
C1q and absence or infrequency of IgA deposition may be helpful for physicians to confirm 
AHEI rather than HSP (Saraclar et al., 1992). Additionally, Goraya (Goraya et al., 2002) and 
Shah (Shah et al., 2002) reported that the observed immunohistologic differences between 
the two diseases are secondary to the immaturity of the IgA immune system at the ages of 
12 and 24 months. In these age groups the IgA levels are at 19% and 25% of adult values, 
respectively. So, this might explain the observed clinical and immunologic differences 
between these two disorders.  
The other differential diagnosis of AHEI includes meningococcemia, erythema multiforme, 
Kawasaki disease, purpura fulminans, eruptions of viral infections, drug-induced vasculitis, 
septic vasculitis, Sweet’s syndrome (acute febrile neutrophilic dermatosis), dermatologic 
manifestations of hematologic diseases and child abuse (Caksen et al., 2002; Cunningham et 
al., 1996; Dubin et al., 1990; Ince et al., 1995; Legrain et al., 1991; Saraclar et al., 1990; Smitt et 
al., 2002). All these disorders can be differentiated from AHEI by results of history, physical 
examination and appropriate laboratory studies, including examination of skin biopsy 
specimen.  
10. Treatment 
There is no specific treatment for AHEI because of its natural course. Multiple treatments 
have been reported to be beneficial, such as topical hydrocortisone 1% cream twice daily 
(Long & Helm, 1998), systemic prednisone with a dose of 1.5-2 mg/kg/day (Dubin et al., 
1990; Ince et al., 1995; Poyrazoglu et al., 2003), prednisolone with a dose of 0.5-1 
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mg/kg/day (AlSufyani, 2009; Blasini et al., 2007; da Silva Manzoni et al., 2004; Halıcıoglu 
et al., 2010; Roh et al., 2004), methylprednisolone with a dose of 1 mg/kg twice daily 
(Garty et al., 2006) and betamethasone with a dose of 1 mg/kg/day (Paradisi et al., 2001). 
Also, oral antihistamines such as hydroxyzine, diphenhydramine (Alp et al., 2009; Caksen 
et al., 2002; Ince et al., 1995; Poyrazoglu et al., 2003; Tomac et al., 1996), dapson (Gonggryp 
& Todd, 1998) and oral nonsteroidal anti-inflammatory drugs (Karremann et al., 2009, 
Poyrazoglu et al., 2003) have been suggested for management. Some authors believe that 
these treatments have a role in changing the course of the disease (Alp et al., 2009; 
Saraclar et al., 1990), but some do not (Krause et al., 1996; Legrain et al., 1991). Treatments 
with antimicrobials for a confirmed concurrent infection have been shown to be of some 
value during the course of AHEI (Caksen et al., 2002; Colantonio et al., 1997; Garty et al., 
2002; Gonggryp & Todd, 1998; Ince et al., 1995; Karremann et al., 2009; Morrison & 
Saulsbury, 1999; Tomac et al., 1996).  
11. Prognosis 
AHEI is generally benign and self-limited. Spontaneous and complete resolution occurs 
within 4-24 days (Acun et al., 2006; Alp et al., 2009; AlSufyani, 2009; Blasini et al., 2007; 
Braun-Falco & Dietrich Abeck, 2002; Caksen et al., 2002; Calıskan et al., 1995; Can et al., 
2006; Chatproedprai & Wananukul, 2007; Colantonio et al., 1997; Crowe & Jonas, 1998; 
Cunningham et al., 1996, 1999; Bozaykut et al., 2002; da Silva Manzoni et al., 2004; Di Lernia 
et al., 2004; Dubin et al., 1990; Fiore et al., 2008; Fujimura et al., 2001; Garty et al., 2006; 
Gelmetti et al., 1985; Goraya & Kaur, 2002; Gonggryp & Todd, 1998; Gattorno et al., 1997; 
Javidi et al., 2008; Karreman et al., 2009; Krause et al., 1996; Kuroda et al., 2002; Lakshmi & 
Srinivas, 2003; Lantner et al., 1996; Lee et al., 2006; Long & Helm, 1998; Macea et al., 2003; 
Michael, 2006; Millard et al., 1999; Morrison & Saulsbury, 1999; Paradisi et al., 2001; 
Poyrazoglu et al., 2003; Pride et al., 1995; Roh et al., 2004; Saraclar et al., 1990; Saray et al., 
2002; Scaramuzza et al., 1997; Serna et al., 1994; Shah et al., 2002; Silveira et al., 2006; Sites et 
al., 2008; Smitt et al., 2002; Tomac et al., 1996; Watanabe & Sato, 2007; Wong & Harrington, 
2004). Attacks have not been usually reported in the literature. This may because long-term 
follow-up is not available in most cases. However, attacks associated with AHEI have been 
reported in some cases and the duration of these attacks were not completely different from 
the duration of the main disease (Alp et al., 2009; Amitai et al., 1993; Dubin et al., 1990; 
Karreman et al., 2009). With either treatment or a conservative approach, AHEI usually 
resolves completely with no sequelae, but there have been reports of residual 
hyperpigmentation (Saraclar et al., 1990), slight atrophy (Macea et al., 2003) and depressed 
scars instead of cheeks (AlSufyani, 2009). Also, Smitt and colleagues stated that only necrotic 
areas may leave a scar (Smitt et al., 2002). On the other hand, AlSufyani suggested that 
scarring is genuine to the disease process itself and it is not clear whether earlier 
administration of either treatment would have prevented scarring (AlSufyani, 2009). Also, 
complications such as intussuseption (Yu et al., 2007) and torsion of testis (Gelmetti et al., 
1985) have been reported.  
12. Conclusion 
Acute hemorrhagic edema of infancy is an uncommon cutaneous leukocytoclastic vasculitis. 
Various infections, drug use and vaccination are discussed as triggering factors more than 
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90 years after the first description of the disease. Also, the benign and self-limited course 
and excellent prognosis with mild to absent systemic involvement is well established. 
Today, it has been considered as a distinct entity either than a variant of Henoch-Schönlein 
purpura. Physicians might develop the skills necessary to consider the diagnosis of acute 
hemorrhagic edema of infancy when presented with a non-toxic infant having large 
targetoid purpuric lesions and edema in nonpitting character.  
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